You are here

  • Home
  • Archive
  • Volume 9, Issue 12
  • Response to: Correspondence on "G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment" by Mora et al

Citation Tools

Article menu

Download PDFPDF

Letter
Response to: Correspondence on "G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment" by Mora et al

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Martinez Sanz P, van Rees DJ, Matlung HL, et al
Response to: Correspondence on "G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment" by Mora et al
Journal for ImmunoTherapy of Cancer 2021;9:e003983. doi: 10.1136/jitc-2021-003983